Search Results - "Shah, Jay Bakul"

Outcomes with neoadjuvant chemotherapy in bladder-preserving treatment for MIBC by Glover, Michael, Ewongwo, Agnes, Usoz, Melissa, Kornberg, Zachary, Bagshaw, Hilary, Shah, Jay Bakul, Shah, Sumit, Qian, Yushen

“…577 Background: Trimodality bladder preservation is an acceptable alternative to radical cystectomy (RC) for muscle invasive bladder cancer (MIBC). Multiple…”
Get full text

Reducing opioid utilization after urologic oncology surgery by Stevenson, Kerri, Kee, Jessica, Van Zyl, Elizna, Dugala, Anisia, Shah, Jay Bakul

“…Abstract only 269 Background: Multiple sources have reported on widespread abuse of opioid pain medications among Americans. For many patients, the first…”
Get full text

Outcomes and survival in nonbilharzial pure squamous cell bladder cancer in patients undergoing curative radical cystectomy by Kukreja, Janet Baack, Ismaeel, Nourhan, Navai, Neema, Kamat, Ashish M., Dinney, Colin P.N., Shah, Jay Bakul

“…Abstract only 363 Background: Pure squamous cell cancer of the bladder is uncommon in the United States. Because squamous cell bladder cancer is rare, there…”
Get full text

Association of preoperative neutrophil-to-lymphocyte ratio with survival outcomes in patients undergoing radical cystectomy, regardless of neoadjuvant chemotherapy status by Kukreja, Janet Baack, Podolnick, Jason M, Wang, Xuemei, Chen, Hsiang-Chun, Navai, Neema, Kamat, Ashish M., Dinney, Colin P.N., Shah, Jay Bakul

“…Abstract only 352 Background: Pre-operative neutrophil-to-lymphocyte ratio (NLR) has been found to be associated with adverse pathological results and poor…”
Get full text

Association of presurgery neutrophil-to-lymphocyte ratio with survival outcomes in patients with urothelial carcinoma treated without neoadjuvant chemotherapy and with radical cystectomy by Kukreja, Janet Baack, Podolnick, Jason M, Wang, Xuemei, Chen, Hsiang-Chun, Navai, Neema, Kamat, Ashish M., Dinney, Colin P.N., Shah, Jay Bakul

“…Abstract only 324 Background: There is growing interest in finding inexpensive, easily reproducible biomarkers to predict outcomes in patients with urothelial…”
Get full text

Clinical and pathological outcomes for patients with T1HG bladder cancer managed with upfront cystectomy with or without neoadjuvant chemotherapy and the impact of the MDACC high-risk features by Metcalfe, Michael J., Ferguson, James Edward, Li, Roger, Xiao, Lianchun, Dinney, Colin P.N., Navai, Neema, Shah, Jay Bakul, Kamat, Ashish M.

“…Abstract only 366 Background: In muscle invasive bladder cancer there is an increased risk for systemic disease identified for patients with certain high risk…”
Get full text

Measuring and improving symptom burden in radical cystectomy patients undergoing traditional care compared to enhanced recovery by Kukreja, Janet Baack, Chang, Courtney M, Chen, Ting Yu, Shi, Qiuling, Wang, Xin Shelley, Navai, Neema, Kamat, Ashish M., Dinney, Colin P.N., Shah, Jay Bakul

“…Abstract only 340 Background: Bladder cancer is a disease of the elderly associated with high morbidity in those undergoing radical cystectomy (RC). The…”
Get full text

Prevalence of vitamin D insufficiency and falls in older cancer patients by Zhang, Xiaotao, Sun, Ming, Shah, Jay Bakul, Dinney, Colin P.N., Popat, Uday R., Champlin, Richard E., Valero, Vicente, Tripathy, Debu, Hedberg, Ann-Marie, Edwards, Beatrice Jara-Almonte

“…Abstract only 138 Background: More than 60% of cancer patients are older adults. Such patients undergo age and cancer therapy related changes. Older adults…”
Get full text

Primary prevention of bladder cancer: Does the public know the risk factors? by Wood, Erika L., Golla, Vishnukamal, Goswamy, Rohit, Fellman, Bryan, Urbauer, Diana L, Canfield, Steven, Shah, Jay Bakul

“…Abstract only 366 Background: Smoking is the single most significant modifiable risk factor for bladder cancer, yet this is not well known outside of the…”
Get full text

Outcomes in patients with p0 versus PCIS on final cystectomy pathology by Golla, Vishnukamal, Kamat, Ashish M., Dinney, Colin P. N., Grossman, H. Barton, Shah, Jay Bakul

“…Abstract only 312 Background: For patients with superficial bladder cancer, the presence of Carcinoma in situ (CIS) is known to increase the risk of subsequent…”
Get full text

The utility of neutrophil-to-lymphocyte ratio in determining survival outcomes in patients treated with neoadjuvant chemotherapy and radical cystectomy for high-risk bladder cancer by Mmeje, Chinedu O., Slade, Austen, Slack, Rebecca, Navai, Neema, Gao, Jianjun, Siefker-Radtke, Arlene O., Kamat, Ashish M., Dinney, Colin P. N., Shah, Jay Bakul

“…Abstract only 419 Background: Pre-operative neutrophil-to-lymphocyte ratio (NLR) has been found to be associated with adverse pathological results and poor…”
Get full text

Does liposomal bupivacaine use intraoperatively decrease postoperative narcotic use in radical cystectomy patients? by Kukreja, Janet Baack, Chang, Courtney M, Seif, Mohamed, Navai, Neema, Kamat, Ashish M., Dinney, Colin P.N., Shah, Jay Bakul

“…Abstract only 311 Background: Bupivacaine liposome injectable suspension (LB) can be used to help control postoperative pain. It slowly releases bupivacaine…”
Get full text

Measuring success after radical cystectomy: Feasibility of a novel composite endpoint ("poor recovery") to quantify outcomes after surgery by Wood, Erika L., Baack Kukreja, Janet E., Porten, Sima P., Ezeagu, Raphael, Qiao, Wei, Navai, Neema, Kamat, Ashish M., Dinney, Colin P. N., Shah, Jay Bakul

“…Abstract only 357 Background: Given the predilection of invasive bladder cancer toward older sicker patients and the complexity of radical cystectomy (RC), it…”
Get full text

Determining the optimal timing for radical cystectomy after neoadjuvant chemotherapy by Mmeje, Chinedu O., Benson, Cooper, Nogueras-Gonzalez, Graciela M., Jayaratna, Isuru Sampath, Navai, Neema, Gao, Jianjun, Siefker-Radtke, Arlene O., Kamat, Ashish M., Dinney, Colin P. N., Shah, Jay Bakul

“…Abstract only 339 Background: We present the largest series reviewing complications and pathologic outcomes following neoadjuvant chemotherapy (NAC) and…”
Get full text

Outcome of patients with clinically node-positive bladder cancer who undergo consolidative surgery after preoperative chemotherapy: MD Anderson Cancer Center experience by Ho, Philip Levy, Willis, Daniel Levi, Patil, Jeevitha, Tart, Karen, Parikh, Sahil, Shah, Jay Bakul, Delacroix, Scott Edward, Siefker-Radtke, Arlene O., Dinney, Colin P. N., Pisters, Louis L., Kamat, Ashish M.

“…Abstract only 318 Background: We previously reported results of our phase II study in patients with retroperitoneal lymph node (RPLN) metastasis from bladder…”
Get full text

Risk group stratification in patients with micropapillary bladder cancer treated with radical cystectomy and/or neoadjuvant chemotherapy by Williams, Stephen Bentley, Fernandez, Mario, Willis, Daniel Levi, Slack, Rebecca, Siefker-Radtke, Arlene O., Navai, Neema, Dickstein, Rian J., Guo, Charles, Czerniak, Bogdan, McConkey, David James, Parikh, Sahil, Pisters, Louis L., Shah, Jay Bakul, Grossman, H. Barton, Dinney, Colin P. N., Kamat, Ashish M.

“…Abstract only 302 Background: Micropapillary bladder cancer (MPBC) is an aggressive variant of urothelial carcinoma. We have previously published clinical risk…”
Get full text

Active surveillance in phenotypically heterogeneous early-stage prostate cancer by Davis, John W., Achim, Mary F., Ward, John Francis, Pettaway, Curtis Alvin, Chapin, Brian Francis, Wang, Xuemei, Kuban, Deborah A., Frank, Steven J., Lee, Andrew, Pisters, Louis L., Matin, Surena F., Shah, Jay Bakul, Karam, Jose A., Papadopoulos, John N., Hoffman, Karen Elizabeth, Pugh, Thomas J., Choi, Seungtaek, Logothetis, Christopher, Troncoso, Patricia, Kim, Jeri

“…Abstract only…”
Get full text

Management of cT1 micropapillary bladder cancer by Willis, Daniel Levi, Fernandez, Mario, Dickstein, Rian J., Parikh, Sahil, Shah, Jay Bakul, Pisters, Louis L., Guo, Charles, Czerniak, Bogdan, Grossman, H. Barton, Dinney, Colin P.N., Kamat, Ashish M.

“…Abstract only 308 Background: We have previously reported that intravesical BCG is ineffective as therapy for micropapillary variant of bladder cancer. Since…”
Get full text

Does the diagnosing urologist influence choice of initial active treatment versus observation in older men with favorable prostate cancer? by Hoffman, Karen Elizabeth, Niu, Jiangong, Shen, Yu, Jiang, Jing, Shah, Jay Bakul, Smith, Grace L., Davis, John W., Kim, Jeri, Volk, Robert, Kuban, Deborah A., Giordano, Sharon Hermes, Smith, Benjamin D.

“…Abstract only 15 Background: Upfront treatment of older men with favorable prostate cancer yields substantial morbidity but does not improve survival…”
Get full text

Clinical outcomes in focal versus extensive micropapillary bladder cancer at the time of diagnostic transurethral resection by Willis, Daniel Levi, Fernandez, Mario, Dickstein, Rian J., Guo, Charles, Czerniak, Bogdan, Parikh, Sahil, Shah, Jay Bakul, Pisters, Louis L., Grossman, H. Barton, Dinney, Colin P.N., Kamat, Ashish M.

“…Abstract only 317 Background: It has been postulated that the outcome of patients with micropapillary bladder cancer (MPBC) is dependent on the extent of MPBC…”
Get full text